tetrahydrofuran has been researched along with oxazolidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodney, MA; Coffman, KJ; Lee, C; Miller, E; Obach, RS; Rapp, T; Ryder, TF; Sawant-Basak, A; Tseng, E; Vanase-Frawley, MA; Walker, GS; Wong, JW | 1 |
| Duvvuri, S; Kadar, EP; Kimoto, E; Lin, J; Nicholas, T; Obach, RS; Sawant-Basak, A; Tremaine, LM | 1 |
2 other study(ies) available for tetrahydrofuran and oxazolidine
| Article | Year |
|---|---|
Metabolism of a serotonin-4 receptor partial agonist 4-{4-[4-tetrahydrofuran-3-yloxy)-benzo[d]isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol (TBPT): identification of an unusual pharmacologically active cyclized oxazolidine metabolite
Topics: Animals; Blood Proteins; Brain; Cyclization; Dealkylation; Dogs; Female; Furans; Hepatocytes; Humans; Hydroxylation; Male; Microsomes, Liver; Oxazoles; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists | 2013 |
Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug Ratio.
Topics: Adult; Cyclization; Dealkylation; Female; Furans; Hepatocytes; Humans; Inactivation, Metabolic; Kinetics; Male; Middle Aged; Models, Biological; Oxazoles; Serotonin Receptor Agonists; Young Adult | 2018 |